Pierre Le Francier

Title: Innovations of Pierre Le Francier

Introduction

Pierre Le Francier is a notable inventor based in Bures sur Yvette, France. He has made significant contributions to the field of pharmaceuticals through his innovative work on muramyl peptides. His research focuses on the development of novel compounds that have important applications in medicine.

Latest Patents

Pierre Le Francier holds a patent for a unique invention titled "Muramyl peptide substituted on a peptide nitrogen and medicaments." This invention relates to novel compounds of the muramyl-peptide type and their uses. The muramyl-peptides he developed comprise at least two aminoacyl residues in the peptide chain, with the second being D-glutamyl. A key characteristic of these compounds is that the nitrogen of the first amino-acyl, which forms part of the peptide linkage connecting the muramyl group to the peptide residue, is substituted by an alkyl group. These compounds are particularly useful for preparing pharmaceutical compositions due to their regulatory properties on the immune responses of the organism.

Career Highlights

Pierre Le Francier is associated with the Agence Nationale De Valorisation De La Recherche (ANVAR), where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on immune response regulation and pharmaceutical applications.

Collaborations

Throughout his career, Pierre has collaborated with esteemed colleagues, including Francoise Marguerite Audibert and Jean Choay. These collaborations have contributed to the advancement of his research and the successful development of innovative compounds.

Conclusion

Pierre Le Francier's contributions to the field of pharmaceuticals through his innovative work on muramyl peptides highlight the importance of research in developing new medical treatments. His patent reflects a significant advancement in understanding immune responses, showcasing the potential for future applications in medicine.